Congenital Heart Disease clinical trials
Showing 51–69 of 69 active trials. Describe your situation to see which ones look like a fit.
- Cord Clamping Among Neonates With Congenital Heart Disease
- Parent Navigator Program (PNP) to Improve Outcomes in Latino/x Children and Parents
- BOND: Direct Breastfeeding to Enhance Maternal and Infant Health in Congenital Heart Disease
- Tailored MgSO4 Supplementation to Reduce Complications in Pediatric Heart Surgery
- Light Utilization COX-Inhibitory Device Therapy for Infant Cardiac Arrest (LUTICA Study). The LUCID Device is Used in the Treatment of Ischemic Brain Reperfusion Injury Caused by Cardiac Arrest in Pediatric Patients.
- Pharmacokinetic and Pharmacodynamic Investigations of Fetal Anesthesia During Maternal Fetal Surgery
- Conventional Ultrafiltration Versus Dilutional Ultrafiltration in Pediatric CPB Patients
- Occlutech AFR Fontan Study
- Prenatally-initiated Psychological Intervention for Mothers of Infants With Congenital Heart Disease (CHD)
- Butyric Acid Supplementation for Gut Improvement After Cardiac Surgery in Kids
- CHAMP App Cardiac Study and Repository
- Nitric Oxide Effect on Brain and Kidney in Pediatric Patients Undergoing Cardiopulmonary Bypass
- Precision Medicine in the CICU: Identifying Proteomic Biomarkers
- EXCOR Active Driving System for the EXCOR Pediatric VAD IDE Study
- MRI and Computational Simulation Cardiology Study
- Upper Airway Ultrasound to Predict Difficult Laryngoscopy in Neonates and Infants
- Comparative Effectiveness of Gadopiclenol for Evaluation of Adult Congenital Heart Anatomy and Hemodynamics
- The Relationship Between Brain MRI Phenotypes, Genes and Cognitive Outcome in CHD Adults
- Blood Conservation in Patients (3.5-12kg) Undergoing Congenital Cardiac Surgery
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.